Reports and Surveys | March 28, 2024
State leaders’ focus on health benefit coverage has increased as the cost of that coverage continues to outpace overall inflation, placing budgetary pressure on health plan funding and underscoring the need for targeted cost-management strategies.
To achieve cost-effective coverage and maintain competitive offerings, it can be helpful to look at how peer jurisdictions structure their employee health benefits. Comparing programs can provide context and yield valuable insights that help inform plan design decisions.
Segal’s 2024 State Employee Health Benefits Study presents an overview of plan design and cost-sharing arrangements in all 50 states.
Detailed findings are available in an interactive online tool. A report covers the high-level findings. To access both, complete the short form.
Share this page
The study covers medical and prescription drug plan design and benefit cost-sharing arrangements offered to full-time active employees in all 50 states for 2023–2024.
This information, combined with the insights we’ve developed from decades of working with state health plans, makes this study an invaluable resource for decision-makers. Knowing the details about other state employee health benefit plans can help you benchmark your plan design.
The tool allows you to compare, at no charge, your state’s least expensive plan or most expensive plan to other state plans in your region or nationally for the following plan features:
To access the tool, complete the form at the top right of this page.
The report presents high-level, aggregate findings for the least expensive and most expensive plan options. It covers:
Completing the form at the top right of this page will enable you to download the report as well as get basic access to the online tool.
Health, Public Sector
Health, Healthcare Industry, Multiemployer Plans, Public Sector, Higher Education, Corporate
Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, COVID-19, Pharmaceutical, Corporate, Mental Health
This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.
© 2024 by The Segal Group, Inc.Terms & Conditions Privacy Policy California Residents Sitemap Disclosure of Compensation Required Notices
We use cookies to collect information about how you use segalco.com.
We use this information to make the website work as well as possible and improve our offering to you.